Ironwood Pharmaceuticals’ Jeffrey Silber, SVP and CMO, files initial beneficial ownership statement - IRWD News | RalliesIronwood Pharmaceuticals’ Jeffrey Silber, SVP and CMO, files initial beneficial ownership statement
I
IRWD• Form 3 filing for Jeffrey Silber
- Ironwood Pharmaceuticals filed a Form 3 for Jeffrey Silber, SVP, chief medical officer, head of research and drug development.
I
IBM cuts yearly revenue growth forecast as customers prioritize AI infrastructure spending
IBM•
